LSA
HAE icon

Leonteq Securities AG’s Haemonetics HAE Stock Holding History

Leonteq Securities AG’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$675 Sell
9
-360
-98% -$23.1K ﹤0.01% 1201
2026
Q1 		$20.8K Hold
369
– – ﹤0.01% 990
2025
Q4 		$29.6K Sell
369
-1,370
-79% -$92K ﹤0.01% 1040
2025
Q3 		$84.8K Sell
1,739
-1,564
-47% -$96.8K ﹤0.01% 781
2025
Q2 		$246K Sell
3,303
-37
-1% -$2.45K 0.01% 520
2025
Q1 		$212K Buy
3,340
+1,215
+57% +$82.6K 0.01% 532
2024
Q4 		$166K Buy
+2,125
New +$171K 0.01% 584

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Leonteq Securities AG's HAE Position: Q2 2026 in Review

Leonteq Securities AG reduced its Haemonetics (HAE) stake by 98% in Q2 2026, selling an estimated $23.1K and leaving 9 shares worth $675. The position accounts for ﹤0.01% of the portfolio, ranked #1201.

Leonteq Securities AG first reported a position in HAE in Q4 2024 and has held it in 7 quarters since. The position peaked at $246K in Q2 2025. 327 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Leonteq Securities AG held 9 shares of Haemonetics worth $675 as of Q2 2026.
  • Leonteq Securities AG sold 360 Haemonetics shares in Q2 2026, an estimated $23.1K.
  • Haemonetics made up ﹤0.01% of Leonteq Securities AG's portfolio in Q2 2026, its #1201 holding.
  • Leonteq Securities AG first reported a position in Haemonetics in Q4 2024 and has held it in 7 quarters since.
  • Leonteq Securities AG's Haemonetics position peaked at $246K in Q2 2025.
  • 327 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.